Effects of Cisplatin on Testicular Tissue and the Leydig Cell-Pituitary Axis

Oncology (Switzerland)

Volumn 54, Issue 1, 1997, Pages 74-78

  Aydiner, Adrian ^a   Aytekin, Yener ^b   Topuz, Erkan ^a  

^a Institute of Oncology   (Japan)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cisplatin; Hormone; Testis; Testosterone; Ultrastructure

Indexed keywords

CISPLATIN; LUTEINIZING HORMONE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL INCLUSION; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENDOPLASMIC RETICULUM; GERM LAYER; HYPOPHYSIS; INTRAPERITONEAL DRUG ADMINISTRATION; LEYDIG CELL; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RAT; SERTOLI CELL; TESTIS; TESTOSTERONE BLOOD LEVEL;

ANIMALS; CISPLATIN; LEYDIG CELLS; LUTEINIZING HORMONE; MALE; RATS; RATS, SPRAGUE-DAWLEY; SERTOLI CELLS; TESTIS; TESTOSTERONE;

EID: 0031060335     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227665     Document Type: Article

References (12)

1. Rozencweig M, Abele R, Von Hoff DD, Mug-gia FM: Cisplatin: Impact of a new anticancer agent on current therapeutic strategies, Anticancer Res 1981; 1:199-204.
2. Loehrer PJ, Einhom LH: Diagnosis and treatment, Drugs five years later: Cisplatin, Ann Intern Med 1984;100:704-713.
3. Trump DL: Reproductive complications; in AbelofT MD, Armitage JO, Lichter AS, Nie-derhuber JE (eds): Clinical Oncology, New York, Churchill Livingstone, 1995, pp 821-828.
4. Le Blanc GA, Waxman DJ: Feminization of rat hepatic P-450 expression by cisplatin, J Biol Chem 1988;263:15732-15739.
5. Maines MD, Sluss PM, Mumtaz I: cis-Plati-num-mediated decrease in serum testosterone is associated with depression of luteinizing hormone receptors and cytochrome P-450.SCC in rat testis, Endocrinology 1990;126:2398-2406.
6. Maines MD, Mayer RD: Inhibition of testicular cytochrome P-450-dependent steroid biosynthesis by cis-platinum, J Biol Chem 1985; 260:6063-6068.
7. Wallace WHB, Shalet SM, Crowne EC, Morris-Jones PH, Gattamaneni HR, Price DA: Gonadal dysfunction due to cisplatinum, Med Pe-diatr Oncol 1989;17:409-413.
8. Le Blanc GA, Kantoff PW, Fong S, Frei E, Waxman DJ: Hormonal perturbations in patients with testicular cancer treated with cisplatin, Cancer 1992;69:2306-2310.
9. Kopf-Maier P: Effects of carboplatin on the testis, A histological study, Cancer Chemother Pharmacol 1992;29:227-235.
10. Rosen M, Figliomeni M, Simokins H: The interaction of platinum antitumor drugs with mouse liver mitochondria, Int J Exp Pathol 1992;73:61-64.
11. Heywood LH: Testosterone levels in the male laboratory rat: Variation under experimental conditions, Int J Androl 1980;3:519-529.
12. Azcuri H, Bidart JM, Bohuon C: In vivo toxicity of cisplatin and carboplatin on the Leydig cell function and effect of the human choriogonadotropin, Biochem Pharmacol 1989;38: 567-571.